138 related articles for article (PubMed ID: 37236594)
1. Correspondence Concerning PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma.
Torchia D
J Invest Dermatol; 2023 Dec; 143(12):2536-2537. PubMed ID: 37236594
[No Abstract] [Full Text] [Related]
2. PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma.
Polubothu S; Bender N; Muthiah S; Zecchin D; Demetriou C; Martin SB; Malhotra S; Travnickova J; Zeng Z; Böhm M; Barbarot S; Cottrell C; Davies O; Baselga E; Burrows NP; Carmignac V; Diaz JS; Fink C; Haenssle HA; Happle R; Harland M; Majerowski J; Vabres P; Vincent M; Newton-Bishop JA; Bishop DT; Siegel D; Patton EE; Topf M; Rajan N; Drolet B; Kinsler VA
J Invest Dermatol; 2023 Jun; 143(6):1042-1051.e3. PubMed ID: 36566878
[TBL] [Abstract][Full Text] [Related]
3. Mosaic Neurocutaneous Disorders and Their Causes.
Ruggieri M; Praticò AD
Semin Pediatr Neurol; 2015 Dec; 22(4):207-33. PubMed ID: 26706010
[TBL] [Abstract][Full Text] [Related]
4. Phacomatosis pigmentovascularis spilorosea and mutation in the PTPN11 gene: new case with significant neurologic impairment.
Maione V; Soglia S; Miccio L; Calzavara-Pinton P; Napolitano A; Cinquina V; Ritelli M; Colombi M
J Dtsch Dermatol Ges; 2022 Aug; 20(8):1133-1136. PubMed ID: 35698861
[No Abstract] [Full Text] [Related]
5. Genetic Evaluation of Common Neurocutaneous Syndromes.
Gürsoy S; Erçal D
Pediatr Neurol; 2018 Dec; 89():3-10. PubMed ID: 30424961
[TBL] [Abstract][Full Text] [Related]
6. Introduction to phacomatoses (neurocutaneous disorders) in childhood.
Ruggieri M; Polizzi A; Marceca GP; Catanzaro S; Praticò AD; Di Rocco C
Childs Nerv Syst; 2020 Oct; 36(10):2229-2268. PubMed ID: 32940773
[TBL] [Abstract][Full Text] [Related]
7. Copy number abnormalities in new or progressive 'neurocutaneous melanosis' confirm it to be primary CNS melanoma.
Kinsler VA; Polubothu S; Calonje JE; Chong WK; Thompson D; Jacques TS; Morrogh D
Acta Neuropathol; 2017 Feb; 133(2):329-331. PubMed ID: 27933403
[No Abstract] [Full Text] [Related]
8. Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis.
van Engen-van Grunsven AC; Rabold K; Küsters-Vandevelde HV; Rijntjes J; Djafarihamedani M; Hehir-Kwa JY; Küsters B; Willemsen MA; van der Burgt I; Wesseling P; Blokx WA; Groenen PJ
Acta Neuropathol; 2017 Feb; 133(2):333-335. PubMed ID: 27988846
[No Abstract] [Full Text] [Related]
9. Genetics of neurocutaneous disorders: basic principles of inheritance as they apply to neurocutaneous syndromes.
Dies KA; Sahin M
Handb Clin Neurol; 2015; 132():3-8. PubMed ID: 26564068
[TBL] [Abstract][Full Text] [Related]
10. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
11. Scalp melanoma in a woman with LEOPARD syndrome: possible implication of PTPN11 signaling in melanoma pathogenesis.
Cheng YP; Chiu HY; Hsiao TL; Hsiao CH; Lin CC; Liao YH
J Am Acad Dermatol; 2013 Oct; 69(4):e186-7. PubMed ID: 24034393
[No Abstract] [Full Text] [Related]
12. Complete agenesis of the corpus callosum in phacomatosis pigmentovascularis cesioflammea: a manifestation of mosaicism?
Abasq-Thomas C; Audebert S; Carmignac V; Brosseau-Beauvir A; Brenaut E; Misery L; Vabres P
Eur J Dermatol; 2021 Apr; 31(2):248-249. PubMed ID: 34001472
[No Abstract] [Full Text] [Related]
13. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
Kolin DL; Geddie WR; Ko HM
Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
[No Abstract] [Full Text] [Related]
14. Clinical findings of the phakomatoses: hypomelanosis of Ito.
Quigg M; Rust RS; Miller JQ
Neurology; 2006 Jun; 66(12):E45. PubMed ID: 16801637
[No Abstract] [Full Text] [Related]
15. Paradominant inheritance of twin spotting: phacomatosis pigmentovascularis as a further possible example.
Danarti R; Happle R
Eur J Dermatol; 2003; 13(6):612. PubMed ID: 14721790
[No Abstract] [Full Text] [Related]
16. National Cancer Institute Workshop Report: the phakomatoses revisited.
Tucker M; Goldstein A; Dean M; Knudson A
J Natl Cancer Inst; 2000 Apr; 92(7):530-3. PubMed ID: 10749907
[No Abstract] [Full Text] [Related]
17. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
Mitre V; Heym K; Clark GD; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
[TBL] [Abstract][Full Text] [Related]
18.
Hill KS; Roberts ER; Wang X; Marin E; Park TD; Son S; Ren Y; Fang B; Yoder S; Kim S; Wan L; Sarnaik AA; Koomen JM; Messina JL; Teer JK; Kim Y; Wu J; Chalfant CE; Kim M
Mol Cancer Res; 2019 Feb; 17(2):583-593. PubMed ID: 30355677
[TBL] [Abstract][Full Text] [Related]
19. Gene table: monogenic determined neurocutaneous disorders.
Jóźwiak S; Kotulska K
Eur J Paediatr Neurol; 2010 Sep; 14(5):449-51. PubMed ID: 20580890
[TBL] [Abstract][Full Text] [Related]
20. Dohi Memorial Lecture. New aspects of cutaneous mosaicism.
Happle R
J Dermatol; 2002 Nov; 29(11):681-92. PubMed ID: 12484429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
